Table of Contents

• 1.   Market Introduction

  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders

• 2.   Research Servicesology

  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study

• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Asia-Pacific mHealth Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Asia-Pacific mHealth Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Asia-Pacific mHealth Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Asia-Pacific mHealth Market, By Devices Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Blood glucose meters
      2. BP monitors
      3. Pulse oximetry
      4. Neurological monitoring devices
      5. Apnea and sleep monitors
      6. Wearable fitness sensor device and heart rate meters
      7. Others

• 8.   Asia-Pacific mHealth Market, By Services Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Diagnosis services
      2. Monitoring services
      3. Prevention
      4. Treatment
      5. Drug Monitoring and Pharmaceutical Industry
      6. Wellness and healthcare system strengthening solutions

• 9.   Asia-Pacific mHealth Market, By Stakeholders Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Mobile operators
      2. Device vendors
      3. Healthcare providers
      4. Application players

• 10.   Asia-Pacific mHealth Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Cardiovascular diseases
      2. Diabetes
      3. Respiratory diseases
      4. Neurological diseases
      5. Others

• 11.   Asia-Pacific mHealth Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 12.   Market Share Analysis and Competitive Landscape
  •   1. Asia-Pacific Landscape - Key Players, Revenue and Presence
      2. Asia-Pacific Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Asia-Pacific Emerging Companies
      4. Asia-Pacific - Market Share Analysis and Key Regional Players
      5. Asia-Pacific Key Player - Growth Matrix
    
• 13.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Devicess Offered and Financial Layouts)

  •   1. Philips Healthcare
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Omron HealthCare, Inc.
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Bayer Healthcare
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. LifeWatch AG
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Masimo Corporation
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Sanofi S.A.
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Boston Scientific Corporation
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. AT T Inc
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. Medtronic PLC
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Koninklijke Philips N.V..
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11. DexCom, Inc.
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview
      12. AllScripts Healthcare Solutions, Inc.
       12.1. Company Overview
       12.2. Product Portfolio
       12.3. SWOT Analysis
       12.4. Financial Overview
       12.5. Strategic Overview
      13. Cerner Corporation
       13.1. Company Overview
       13.2. Product Portfolio
       13.3. SWOT Analysis
       13.4. Financial Overview
       13.5. Strategic Overview

• 14.   Pre and Post COVID-19 Impact
  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations
    
• 15.   FutureWise SME Key Takeaway Points for Client